cdx-6114
Recombinant proteinexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 4, 2018 (NCT03577886)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Pterin-4-alpha-carbinolamine dehydrataseSupplementation
PCBD1 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03797664 | Phase 1 | Jan 10, 2019 | Codexis Inc., Linear Clinical Research |
| NCT03577886 | Phase 1 | Jul 4, 2018 | Codexis Inc., Linear Clinical Research |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Codexis Inc. | For profit | 2 | 2 | 1 | 2018 |
| Linear Clinical Research | For profit | 2 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1